These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31005771)

  • 1. Untargeted gas chromatography-mass spectrometry-based metabolomics analysis of kidney and liver tissue from the Lewis Polycystic Kidney rat.
    Abbiss H; Maker GL; Gummer JPA; Rawlinson C; Musk GC; Fleming PA; Phillips JK; Boyce MC; Trengove RD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1118-1119():25-32. PubMed ID: 31005771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease.
    Abbiss H; Maker GL; Gummer J; Sharman MJ; Phillips JK; Boyce M; Trengove RD
    Nephrology (Carlton); 2012 Feb; 17(2):104-10. PubMed ID: 22017187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temporal Profile of Kynurenine Pathway Metabolites in a Rodent Model of Autosomal Recessive Polycystic Kidney Disease.
    Pires AS; Gupta S; Barton SA; Vander Wall R; Tan V; Heng B; Phillips JK; Guillemin GJ
    Int J Tryptophan Res; 2022; 15():11786469221126063. PubMed ID: 36329761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of renal tissue hypoxia in a rat model of polycystic kidney disease.
    Ow CP; Abdelkader A; Hilliard LM; Phillips JK; Evans RG
    Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1207-15. PubMed ID: 25209412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with tempol does not significantly ameliorate renal tissue hypoxia or disease progression in a rodent model of polycystic kidney disease.
    Ding A; Kalaignanasundaram P; Ricardo SD; Abdelkader A; Witting PK; Broughton BR; Kim HB; Wyse BF; Phillips JK; Evans RG
    Clin Exp Pharmacol Physiol; 2012 Nov; 39(11):917-29. PubMed ID: 23006058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dimethyl fumarate on renal disease progression in a genetic ortholog of nephronophthisis.
    Oey O; Rao P; Luciuk M; Mannix C; Rogers NM; Sagar P; Wong A; Rangan G
    Exp Biol Med (Maywood); 2018 Mar; 243(5):428-436. PubMed ID: 29436846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GC-MS-based metabolomics reveals mechanism of action for hydrazine induced hepatotoxicity in rats.
    Bando K; Kunimatsu T; Sakai J; Kimura J; Funabashi H; Seki T; Bamba T; Fukusaki E
    J Appl Toxicol; 2011 Aug; 31(6):524-35. PubMed ID: 21154879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased water intake reduces long-term renal and cardiovascular disease progression in experimental polycystic kidney disease.
    Sagar PS; Zhang J; Luciuk M; Mannix C; Wong ATY; Rangan GK
    PLoS One; 2019; 14(1):e0209186. PubMed ID: 30601830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
    Jeewandara TM; Ameer OZ; Boyd R; Wyse BF; Underwood CF; Phillips JK
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):353-60. PubMed ID: 25676668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
    Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
    J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring metabolic alterations associated with death from asphyxia and the differentiation of asphyxia from sudden cardiac death by GC-HRMS-based untargeted metabolomics.
    Zhang K; Yan H; Liu R; Xiang P; Deng K; Zhang J; Tuo Y; Wang Z; Huang P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 May; 1171():122638. PubMed ID: 33744599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of prenatal and postnatal maternal environment on nephron endowment, renal function and blood pressure in the Lewis polycystic kidney rat.
    Ding A; Walton SL; Moritz KM; Phillips JK
    J Dev Orig Health Dis; 2019 Apr; 10(2):154-163. PubMed ID: 30274564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomic study of aging in mouse plasma by gas chromatography-mass spectrometry.
    Seo C; Hwang YH; Kim Y; Joo BS; Yee ST; Kim CM; Paik MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1025():1-6. PubMed ID: 27183212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GC-MS determination of metabolites in rat kidneys].
    Liu S; Wang F; Mei W; Tao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 38(7):661-9. PubMed ID: 23908085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Untargeted GC-MS Metabolomics.
    Papadimitropoulos MP; Vasilopoulou CG; Maga-Nteve C; Klapa MI
    Methods Mol Biol; 2018; 1738():133-147. PubMed ID: 29654587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined metabolomic and correlation networks analyses reveal fumarase insufficiency altered amino acid metabolism.
    Hou E; Li X; Liu Z; Zhang F; Tian Z
    Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29130499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiplatform metabolomics provides insight into the molecular basis of chronic kidney disease.
    Kordalewska M; Macioszek S; Wawrzyniak R; Sikorska-Wiśniewska M; Śledziński T; Chmielewski M; Mika A; Markuszewski MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jun; 1117():49-57. PubMed ID: 30999273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary metabonomics study in a rat model in response to protein-energy malnutrition by using gas chromatography-mass spectrometry and liquid chromatography-mass spectrometry.
    Wu Z; Li M; Zhao C; Zhou J; Chang Y; Li X; Gao P; Lu X; Li Y; Xu G
    Mol Biosyst; 2010 Nov; 6(11):2157-63. PubMed ID: 20717558
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.